<DOC>
	<DOC>NCT03089073</DOC>
	<brief_summary>Observation of safety and efficacy of Minirin Melt® in adult patients with nocturia</brief_summary>
	<brief_title>Study of Minirin Melt® in Adult Patients With Nocturia</brief_title>
	<detailed_description />
	<mesh_term>Nocturia</mesh_term>
	<mesh_term>Deamino Arginine Vasopressin</mesh_term>
	<criteria>Adult aged between 19 and 65 years Patients having nocturia Decision made to prescribe Minirin Melt according to prescription information Willingness and ability to provide written informed consent When patients have habitual or psychogenic polydipsia (resulting in a urine production exceeding 40ml/kg/24hours) When patients have a history of known or suspected cardiac insufficiency and other conditions requiring treatment with diuresis When patients have moderate and severe renal insufficiency (creatinine clearance below 50ml/min) When patients have known hyponatremia When patients have secretion Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH) When patients have hypersensitivity to the active substances or to any of the excipients</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>